{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:43:58Z","timestamp":1773276238292,"version":"3.50.1"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2003,3,1]],"date-time":"2003-03-01T00:00:00Z","timestamp":1046476800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Langenbecks Arch Surg"],"published-print":{"date-parts":[[2003,3]]},"DOI":"10.1007\/s00423-003-0368-4","type":"journal-article","created":{"date-parts":[[2019,12,11]],"date-time":"2019-12-11T22:13:01Z","timestamp":1576102381000},"page":"17-26","source":"Crossref","is-referenced-by-count":24,"title":["Prophylactic thyroidectomy in multiple endocrine neoplasia: the impact of molecular mechanisms of RET proto-oncogene"],"prefix":"10.1007","volume":"388","author":[{"given":"Andrea","family":"Frilling","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Weber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carsten","family":"Tecklenborg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph Erich","family":"Broelsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2003,3,25]]},"reference":[{"key":"0368_CR1","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/BF00353769","volume":"18","author":"Frilling","year":"1994","unstructured":"Frilling A, R\u00f6her H-D, Ponder BAJ (1994) Presymptomatic screening for medullary thyroid carcinoma in patients with multiple endocrine neoplasia type 2A. World J Surg 18:557\u2013582","journal-title":"World J Surg"},{"key":"0368_CR2","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/328528a0","volume":"328","author":"Simpson","year":"1987","unstructured":"Simpson NE, Kidd KK, Goodfellow PJ, McDermid H, Myers S, Kid JR, Jackson CE, Duncan AM, Farrer LA, Brasch K (1987) Assignment of multiple endocrine neoplasia type 2a to chromosome 10 by linkage. Nature 328:528\u2013530","journal-title":"Nature"},{"key":"0368_CR3","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/328527a0","volume":"328","author":"Matthew","year":"1987","unstructured":"Matthew CGP, Chin KS, Easton DF, Thorpe K, Carter C, Ilou GI, Fong S-L, Bridges CDB, Haak H, Nieuwenhuijzen Kruseman AC, Schifter S, Hansen HH, Telenius H, Telenius-Berg M, Ponder BAJ (1987) A linked genetic marker for multiple endocrine neoplasia type 2A on chromosome 10. Nature 328:527\u2013528","journal-title":"Nature"},{"key":"0368_CR4","first-page":"851","volume":"2","author":"Donis-Keller","year":"1993","unstructured":"Donis-Keller H, Dou S, Chi D, Carlson KM, Toshima K, Lairmore TC, Howe JR, Moley JF, Goodfellow P, Wells SA (1993) Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC Hum Mol Genet 2:851\u2013856","journal-title":"oncogene are associated with MEN 2A and FMTC Hum Mol Genet"},{"key":"0368_CR5","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/363458a0","volume":"363","author":"Mulligan","year":"1993","unstructured":"Mulligan LM, Kwok JB, Healey CS, Elsdon MJ, Eng C, Gardner E, Love DR, Mole SE, Moore JK, Papi L, Ponder MA, Telenius H, Tunnacliffe A, Ponder BAJ (1993) Germ-line mutation of RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature 363:458\u2013460","journal-title":"Nature"},{"key":"0368_CR6","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/367380a0","volume":"367","author":"Schuchardt","year":"1994","unstructured":"Schuchardt A, D\u00e0gati V, Larsson-Blomberg L, Costantini F, Pachnis V (1994) Defects in the kidney and enteric nervous sytem of mice lacking the tyrosine kinase receptor Ret. Nature 367:380\u2013383","journal-title":"Nature"},{"key":"0368_CR7","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1136\/jmg.37.11.817","volume":"37","author":"Hansford","year":"2000","unstructured":"Hansford JR, Mulligan LM (2000) Multiple endocrine neoplasia type 2 and RET: from neoplasia to neurogenesis. J Med Genet 37:817\u2013827","journal-title":"J Med Genet"},{"key":"0368_CR8","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/382080a0","volume":"382","author":"Treanor","year":"1996","unstructured":"Treanor JJS, Goodman L, de Sauvage F, Stone DM, Poulsen KT, Beck CD, Gray C, Armanini MP, Pollock RA, Hefti F, Phillips HS, Goddard A, Moore MW, Buj-Bello A, Davies AM, Asai N, Takahas M, Vandlen R, Henderson CE, Rosenthal A (1996) Characterization of a multicomponent receptor for GDNF. Nature 382:80\u201383","journal-title":"Nature"},{"key":"0368_CR9","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/381785a0","volume":"381","author":"Trupp","year":"1996","unstructured":"Trupp M, Arenas E, Fainzilber M, Nilsson AS, Sieber BA, Grigoriou M, Kilkenny C, Salazar-Gruezo E, Pachnis V, Arumae U (1996) Functional receptor for GDNF encoded by the c-RET proto-oncogene. Nature 381:785","journal-title":"Nature"},{"key":"0368_CR10","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/S1359-6101(01)00012-0","volume":"12","author":"Takahashi","year":"2001","unstructured":"Takahashi M (2001) The GDNF\/RET signaling pathway and human disease. Cytokine Growth Factor Rev 12:361\u2013373","journal-title":"Cytokine Growth Factor Rev"},{"key":"0368_CR11","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/S0092-8674(00)81311-2","volume":"85","author":"Jing","year":"1996","unstructured":"Jing S, Wen D, Yu Y, Holst PL, Luo Y, Fang M, Tamir R, Antonio L, Cupples R. Louis JC, Hu S, Altrock BW, Fox GM (1996) GDNF-induce activation of the RET protein tyrosine kinase is mediated by GDNFR-a, a novel receptor for GDNF. Cell 85:1113\u20131124","journal-title":"Cell"},{"key":"0368_CR12","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/S0896-6273(00)80649-2","volume":"21","author":"Baloh","year":"1998","unstructured":"Baloh RH, Tansey MG, Lampe PA, Fahrner TJ, Enomoto H, Simburger KS, Leitner ML, Araki T, Johnson EM Jr, Milbrandt J (1998) Artemin, a novel member of the GDNF ligand family, supports peripheral and central neurons and signals through the GFRa2-RET receptor complex. Neuron 21:1291\u20131302","journal-title":"Neuron"},{"key":"0368_CR13","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/32474","volume":"392","author":"Klein","year":"1998","unstructured":"Klein RD, Sherman D, Ho WH, Stone D, Bennett GL, Moffat B, Vandlen R, Simmons L, Gu Q, Hongo JA, Devaux B, Poulsen K, Armanini M, Nozaki C, Asai N, Goddard A, Phillips H, Henderson CE, Takahashi M, Rosenthal A (1998) A gpi-linked protein that interacts with RET to form a candidate neurturin receptor. Nature 392:210","journal-title":"Nature"},{"key":"0368_CR14","doi-asserted-by":"publisher","first-page":"20885","DOI":"10.1074\/jbc.274.30.20885","volume":"274","author":"Trupp","year":"1999","unstructured":"Trupp M, Scott R, Whittemore SR, Ibanez CF (1999) Ret-dependent and -independent mechanisms of glial cell line-derived neurotrophic factor signalling in neuronal cells. J Biol Chem 274:20885\u201320894","journal-title":"J Biol Chem"},{"key":"0368_CR15","first-page":"571","volume":"3","author":"Takahashi","year":"1988","unstructured":"Takahashi M, Buma Y, Iwamoto T, Inaguma Y, Ikeda H, Hiai H (1988) Cloning and expression of the ret proto-oncogene encoding a tyrosine kinase with two potential transmembrane domains. Oncogene 3:571\u2013578","journal-title":"Oncogene"},{"key":"0368_CR16","doi-asserted-by":"publisher","first-page":"35808","DOI":"10.1074\/jbc.M104968200","volume":"276","author":"Anders","year":"2001","unstructured":"Anders J, Kjar S, Ibanez CF (2001) Molecular modelling of the extracellular domain of the RET receptor tyrosine kinase reveals multiple cadherin-like domain and calcium-binding site. J Biol Chem 276:35808\u201335817","journal-title":"J Biol Chem"},{"key":"0368_CR17","first-page":"2039","volume":"11","author":"Myers","year":"1995","unstructured":"Myers SM, Eng C, Ponder BAJ, Mulligan LM (1995) Characterization of RET proto-oncogene 3'splicing variants and polyadenylation sites: a novel C terminus for RET. Oncogene 11:2039\u20132045","journal-title":"Oncogene"},{"key":"0368_CR18","doi-asserted-by":"publisher","first-page":"3568","DOI":"10.1074\/jbc.275.5.3568","volume":"275","author":"Segouffin-Cariou","year":"2000","unstructured":"Segouffin-Cariou C, Billaud M (2000) Transforming ability of MEN2A-RET requires activation of the phosphatidylinositol 3-kinase\/AKT signaling pathway. J Biol Chem 275:3568\u20133576","journal-title":"J Biol Chem"},{"key":"0368_CR19","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1136\/jmg.37.11.817","volume":"37","author":"Hansford","year":"2000","unstructured":"Hansford JR, Mulligan LM (2000) Multiple endocrine neoplasia type 2 and RET: from neoplasia to neurogenesis. J Med Genet 37:817\u2013827","journal-title":"J Med Genet"},{"key":"0368_CR20","doi-asserted-by":"publisher","first-page":"4469","DOI":"10.1038\/sj.onc.1203799","volume":"19","author":"Hayashi","year":"2000","unstructured":"Hayashi H, Ichihara M, Iwashita T, Murakami H, Shimono Y, Kumi K, Kurokawa K, Yoshiki M, Imai T, Funahashi H, Nakao A, Takahashi M (2000) Characterization of intracellular signals via tyrosine 1062 in RET activated by glial cell line-derived neurotrophic factor. Oncogene 19:4469\u20134475","journal-title":"Oncogene"},{"key":"0368_CR21","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/S0006-291X(02)00886-0","volume":"296","author":"Borrello","year":"2002","unstructured":"Borrello MG, Mercalli E, Perego C, Degl Innocenti D, Ghizzoni S, Arighi E, Eroini B, Rizzetti BG, Pierotti MA (2002) Differential interaction of Enigma protein with the two RET isoforms. Biochem Biophys Res Commun 296:515\u2013522","journal-title":"Biochem Biophys Res Commun"},{"key":"0368_CR22","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1038\/sj.onc.1204290","volume":"20","author":"Kurokawa","year":"2001","unstructured":"Kurokawa K, Iwashita T, Murakami H, Hayashi H, Kawai K, Takahashi M (2001) Identification of SNT\/FRS2 docking site on RET receptor tyrosine kinase and its role for signal transduction. Oncogene 20:1929\u20131938","journal-title":"Oncogene"},{"key":"0368_CR23","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1006\/bbrc.1999.1186","volume":"262","author":"Murakami","year":"1999","unstructured":"Murakami H, Iwashita T, Asai N, Shimono Y, Iwata Y, Kawai K, Takahashi M (1999) Enhanced phosphatidylinositol 3-kinase activity and high phosphorylation state of its downstream signaling molecules mediated by Ret with the MEN 2B mutation. Biochem Biophys Res Commun 262:68\u201375","journal-title":"Biochem Biophys Res Commun"},{"key":"0368_CR24","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1038\/sj.onc.1201778","volume":"16","author":"Chiariello","year":"1998","unstructured":"Chiariello M, Visconti R, Carlomagno F, Melillo MM, Bucci C, de Franciscis V, Fox GM, Jing S, Coso OA, Gutkind JS, Fusco A, Santoro M (1998) Signaling of the RET receptor tyrosine kinase through the c-Jun NH2-terminal protein kinase (JNKS): evidence for a divergence of the ERKs and JNKs pathways induced by Ret. Oncogene 16:2435\u20132445","journal-title":"Oncogene"},{"key":"0368_CR25","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1365-2796.1995.tb01205.x","volume":"238","author":"Donis-Keller","year":"1995","unstructured":"Donis-Keller H (1995) The RET proto-oncogene and cancer. J Int Med 238:319\u2013325","journal-title":"J Int Med"},{"key":"0368_CR26","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1365-2796.1995.tb01208.x","volume":"238","author":"Mulligan","year":"1995","unstructured":"Mulligan LM, Marsh JD, Robinson BG, Schuffenecker I, Zedenius J, Lips CJ, Gagel RF, Takai S-I, Noll WW, Fink M, Raue F, Lacroix A, Thibodeau SN, Frilling A, Ponder BAJ, Eng C (1995) Genotype-phenotype correlation in multiple endocrine neoplasia type 2: report of the International RET Mutation Consortium. J Intern Med 238:343\u2013346","journal-title":"J Intern Med"},{"key":"0368_CR27","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1001\/jama.1996.03540190047028","volume":"276","author":"Eng","year":"1996","unstructured":"Eng C, Clayton D, Schuffenecker I, Lenoir G, Cote G, Gagel RF, Ploos van Amste HK, Lips CJM, Nishisho I, Takai S-I, Marsh DJ, Robinson BG, Frank-Raue K, Raue F, Xue F, Noll WW, Romei C, Pacini F, Fink M, Niederle B, Zedenius J, Nordenskj\u00f6ld M, Komminoth P, Hendy GN, Gharib H, Thibodeau SN, Lacroix A, Frilling A, Ponder BAJ, Mulligan LM (1996) The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis. JAMA 276:1575\u20131579","journal-title":"JAMA"},{"key":"0368_CR28","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1093\/hmg\/3.12.2163","volume":"3","author":"Mulligan","year":"1994","unstructured":"Mulligan LM, Eng C, Attie T, Lyonnet S, Marsh DJ, Hyland VJ, Robinson BG, Frilling A, Verellen-Dumoulin C, Safar A, Venter DJ, Munnich A Ponder BAJ (1994) Diverse phenotypes associated with exon 10 mutations of the RET proto-oncogene. Hum Mol Genet 3:2163\u20132167","journal-title":"Hum Mol Genet"},{"key":"0368_CR29","first-page":"1780","volume":"81","author":"Frank-Raue","year":"1996","unstructured":"Frank-Raue K, H\u00f6ppner W, Frilling A, Kotzerke J, Dralle H, Haas R, Mann K, Seif F, Kirchner R, Rendl J, Deckart HF, Ritter MM, Hampel R, Klempa J, Scholz GH, Group GMTCS (1996) Mutations of the RET proto-oncogene in German MEN families: relation between genotype and phenotype. J Clin Endocrinol Metab 81:1780\u20131783","journal-title":"J Clin Endocrinol Metab"},{"key":"0368_CR30","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1093\/hmg\/3.11.1939","volume":"3","author":"Schuffenecker","year":"1994","unstructured":"Schuffenecker I, Billaud M, Calender A, Chambe B, Ginet N, Calmettes C, Modigliani E, Lenoir GM (1994) RET proto-oncogene mutations in French MEN 2A and FMTC families. Hum Mol Genet 3:1939\u20131943","journal-title":"Hum Mol Genet"},{"key":"0368_CR31","first-page":"509","volume":"10","author":"Eng","year":"1995","unstructured":"Eng C, Smith DP, Mulligan LM, Healey CS, Zvelebil MJ, Stonehouse TJ, Ponder MA, Jackson CE, Waterfield MD, Ponder BA (1995) A novel point mutation in the tyrosine kinase domain of the RET proto-oncogene in sporadic medullary thyroid carcinoma and in a family with FMTC. Oncogene 10:509\u2013513","journal-title":"Oncogene"},{"key":"0368_CR32","first-page":"770","volume":"83","author":"Berndt","year":"1998","unstructured":"Berndt I, Reuter M, Saller B, Frank-Raue K, Groth, Grussendorf M, Raue F, Ritter MM, H\u00f6ppner W (1998) A new hot spot for mutations in the RET proto-oncogene causing familial medullary thyroid carcinoma and multiple endocrine neoplasia type 2A. J Clin Endocrinol Metab 83:770\u2013774","journal-title":"J Clin Endocrinol Metab"},{"key":"0368_CR33","first-page":"2415","volume":"10","author":"Bolino","year":"1995","unstructured":"Bolino A, Schuffenecker I, Yin L, Seri M, Silengo M, Tocco T, Chabrier G, Houdent C, Murat A, Schlumberger M, Tourniaire J, Lenoir GM, Romeo G (1995) RET mutations in exons 13 and 14 of FMTC patients. Oncogene 10:2415\u20132419","journal-title":"Oncogene"},{"key":"0368_CR34","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/humu.1380110156","volume":"1","author":"Fattoruso","year":"1998","unstructured":"Fattoruso O, Quadro L, Libroia A, Verga U, Lupoli G, Cascone E, Colantuoni V (1998) A GTG to ATG novel point mutation at codon 804 in exon 14 of the RET proto-oncogene in two families affected by familial medullary thyroid carcinoma. Hum Mutat 1:167\u2013171","journal-title":"Hum Mutat"},{"key":"0368_CR35","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1067\/msy.2000.107103","volume":"128","author":"Feldmann","year":"2000","unstructured":"Feldmann GL, Edmonds MW, Ainsworth PJ, Schuffenecker I, Lenoir GM, Saxe AW, Talpos GB, Roberson J, Petrucelli N, Jackson CE (2000) Variable expression of familial medullary thyroid carcinoma (FMTC) due to a RET V804 M (CTG\u2192ATG) mutation. Surgery 128:93\u201398","journal-title":"Surgery"},{"key":"0368_CR36","doi-asserted-by":"crossref","first-page":"3746","DOI":"10.1210\/jcem.86.8.7767","volume":"86","author":"Niccoli-Sire","year":"2001","unstructured":"Niccoli-Sire P, Murat A, Rohmer V, Franc S, Chabrier G, Baldet L, Maes B, Frederique S, Giraud S, Bezieau S, Kottler ML, Morange S, Conte-Devolx B, The French Tumor Study Group (GETC) (2001) Familial medullary thyroid carcinoma with noncysteine RET mutations: phenotype-genotype relationship in a large series of patients. J Clin Endocrinol Metab 86:3746\u20133753","journal-title":"J Clin Endocrinol Metab"},{"key":"0368_CR37","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.1210\/jcem.82.11.4508","volume":"82","author":"Gimm","year":"1997","unstructured":"Gimm O, Marsh DJ, Andrew SD, Frilling A, Dahia PLM, Mulligan LM, Zajac JD, Robinson BG, Eng C (1997) Germline dinucleotide mutation in codon 883 of the RET proto-oncogene in multiple endocrine neoplasia type 2B without codon 918 mutation. J Clin Endocrinol Metab 82:3902\u20133904","journal-title":"J Clin Endocrinol Metab"},{"key":"0368_CR38","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1530\/eje.0.1410468","volume":"141","author":"Niccoli-Sire","year":"1999","unstructured":"Niccoli-Sire P, Murat A, Baudin E, Henry JF, Proye C, Bigorgne JC, Bstandig B, Modigliani E, Morange S, Schlumberger M, Conte-Devoix B, The French Tumor Study Group (GETC) (1999) Early or prophylactic thyroidectomy in MEN 2\/FMTC gene carriers: results in 71 thyroidectomized patients. Eur J Endocrinol 141:468\u2013474","journal-title":"Eur J Endocrinol"},{"key":"0368_CR39","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1097\/00000658-200211000-00006","volume":"236","author":"Fitze","year":"2002","unstructured":"Fitze G, Scherz M, Bredow J, Saeger HD, Roesner D, Schackert HK (2002) Various penetrance of familial medullary thyroid carcinoma in patients with RET protooncogene codon 790\/791 germline mutations. Ann Surg 236:570\u2013575","journal-title":"Ann Surg"},{"key":"0368_CR40","doi-asserted-by":"publisher","first-page":"3919","DOI":"10.1038\/sj.onc.1202742","volume":"18","author":"Iwashita","year":"1999","unstructured":"Iwashita T, Kato M, Murakami H, Asai N, Ishiguro Y, Ito S, Iwata Y, Kawai K, Asai M, Kurokawa K, Kajta H, Takahiashi M (1999) Biological and biochemical properties of Ret with kinase domain mutations identified in multiple endocrine neoplasia type 2b and familial medullary thyroid carcinoma. Oncogene 18:3919\u20133922","journal-title":"Oncogene"},{"key":"0368_CR41","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1038\/sj.onc.1201413","volume":"15","author":"Bocciardi","year":"1997","unstructured":"Bocciardi R, Mograbi B, Pasini B, Borello MG, Pierotti MA, Bourget I, Fischer S, Romeo Giovanni, Rossi B (1997) The multiple endocrine neoplasia type 2B point mutation switches the specificity of the Ret tyrosine kinase towards cellular substrates that are susceptible to interact with Crk and Nck. Oncogene 15:2257\u20132265","journal-title":"Oncogene"},{"key":"0368_CR42","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1038\/sj.onc.1201481","volume":"15","author":"Smith","year":"1997","unstructured":"Smith DP, Houghton C, Ponder BAJ (1997) Germline mutation of RET codon 883 in two cases of de novo MEN 2B. Oncogene 15:1213\u20131217","journal-title":"Oncogene"},{"key":"0368_CR43","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1055\/s-2000-5806","volume":"108","author":"Bartsch","year":"2000","unstructured":"Bartsch DK, Hasse C, Schug C, Barth P, Rothmund M, H\u00f6ppner W (2000) A RET double mutation in the germline of a kindred with FMTC. Exp Clin Endocrinol Diabetes 108:128\u2013132","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"0368_CR44","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1055\/s-2000-8126","volume":"108","author":"Koch","year":"2000","unstructured":"Koch CA, Huang S, Vortmeyer AO, Zhuang Z, Chrousos GP, Pacak K (2000) A patient with MEN 2 and multiple mutations of RET in the germline. Exp Clin Endocrinol Diabetes 108:493","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"0368_CR45","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1093\/hmg\/6.4.587","volume":"6","author":"H\u00c3\u00b6ppner","year":"1997","unstructured":"H\u00f6ppner W, Ritter MM (1997) A duplication of 12 bp in the critical cysteine rich domain of the RET proto-oncogene results in a distinct phenotype of multiple endocrine neoplasia type 2A. Hum Mol Genet 6:587\u2013590","journal-title":"Hum Mol Genet"},{"key":"0368_CR46","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/humu.1380110143","volume":"1","author":"H\u00c3\u00b6ppner","year":"1998","unstructured":"H\u00f6ppner W, Dralle H, Brabant G (1998) A duplication of 9 base pairs in the critical cysteine rich domain of the RET proto-oncogene causes multiple endocrine neoplasia type 2A. Hum Mutat 1:128\u2013130","journal-title":"Hum Mutat"},{"key":"0368_CR47","first-page":"3522","volume":"84","author":"Tessitore","year":"1999","unstructured":"Tessitore A, Sinisi AA, Pasquali D, Cardone M, Vitale D, Bellastella A, Collantuoni V (1999) A novel case of multiple endocrine neoplasia type 2A associated with two de novo mutations of the RET proto-oncogene. J Clin Endocrinol Metab 84:3522\u20133527","journal-title":"J Clin Endocrinol Metab"},{"key":"0368_CR48","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1542\/peds.106.6.1494","volume":"106","author":"Committee","year":"2000","unstructured":"Committee on Genetics (2000) Molecular genetic testing in pediatric practice: a subject review. Pediatrics 106:1494\u20131497","journal-title":"Pediatrics"},{"key":"0368_CR49","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1007\/s002689900547","volume":"22","author":"Delbridge","year":"1998","unstructured":"Delbridge L, Robinson B (1998) Genetic and biochemical screening for endocrine disease. III. Costs and logistics. World J Surg 22:1212\u20131217","journal-title":"World J Surg"},{"key":"0368_CR50","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0022-3468(96)90343-7","volume":"1","author":"Skinner","year":"1996","unstructured":"Skinner MA, De Benedetti MK, Moley JF, Norton JA, Wells SA (1996) Medullary thyroid carcinoma in children with multiple endocrine neoplasia types 2A and 2B. J Pediatr Surg 1:177\u2013181, discussion 181\u2013182","journal-title":"J Pediatr Surg"},{"key":"0368_CR51","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/00000658-199409000-00002","volume":"220","author":"Wells","year":"1994","unstructured":"Wells SA Jr, Chi DD, Toshima K, Dehner LP, Coffin CM, Dowton B, Ivanovich JL, DeBenedetti MK, Dilley WG, Moley JF, Norton JA, Donis-Keller H (1994) Predictive DNA testing and prophylactic thyroidectomy in patients at risk for multiple endocrine neoplasia type 2A. Ann Surg 220:237\u2013250","journal-title":"Ann Surg"},{"key":"0368_CR52","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1055\/s-0029-1211946","volume":"106","author":"Wells","year":"1998","unstructured":"Wells SA Jr, Skinner MA (1998) Prophylactic thyroidectomy, based on direct genetic testing, in patients at risk for multiple endocrine neoplasia type 2 syndromes. Exp Clin Endocrinol Diabetes 106:29\u201334","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"0368_CR53","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1007\/s002689900463","volume":"22","author":"Dralle","year":"1998","unstructured":"Dralle H, Gimm O, Simon D, Frank-Raue K, G\u00f6rtz G, Niederle B, Wahl RA, Koch B, Walgenbach S, Hampel R, Ritter MM, Spelsberg F, Heiss A, Hinze R, H\u00f6ppner W (1998) Prophylactic thyroidectomy in 75 children and adolescents with hereditary medullary thyroid carcinoma: German and Austrian experience. World J Surg 22:744\u2013751","journal-title":"World J Surg"},{"key":"0368_CR54","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S1072-7515(02)01220-6","volume":"195","author":"Rodriquez","year":"2002","unstructured":"Rodriquez Gonzales JM, Balsalobre MD, Pomares F, Torregrosa NM, Rios A, Carbonell P, Glower G, Sola J, Tebar J, Parrilla P (2002) Prophylactic thyroidectomy in MEN 2A syndrome: experience in a single center. J Am Coll Surg 195:159\u2013166","journal-title":"J Am Coll Surg"},{"key":"0368_CR55","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1001\/archsurg.1997.01430330088015","volume":"132","author":"Learoyd","year":"1997","unstructured":"Learoyd DL, Marsh DJ, Richardson AL, Twigg SM, Delbridge L, Robinson BG (1997) Genetic testing for familial cancer. Arch Surg 132:1022\u20131025","journal-title":"Arch Surg"},{"key":"0368_CR56","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/S0022-3468(98)90656-X","volume":"33","author":"Lallier","year":"1998","unstructured":"Lallier M, St-Vil D, Giroux M, Huot C, Gabourcy L, Oligny L, Desjardins JG (1998) Prophylactic thyroidectomy for medullary thyroid carcinoma in gene carriers of MEN 2 syndrome. J Pediatr Surg 33:846\u2013848","journal-title":"J Pediatr Surg"},{"key":"0368_CR57","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1677\/joe.0.1700661","volume":"170","author":"Klein","year":"2001","unstructured":"Klein I, Esik O, Homolya V, Szeri F, Varadi A (2001) Molecular genetic diagnostic program of multiple endocrine neoplasia type 2A and familial thyroid carcinoma syndromes in Hungary. J Endocrinol 170:661\u2013666","journal-title":"J Endocrinol"},{"key":"0368_CR58","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/S0039-6060(05)80110-2","volume":"118","author":"Pacini","year":"1995","unstructured":"Pacini F, Romei C, Miccoli P, Elisei R, Molinaro E, Mancusi F (1995) Early treatment of hereditary medullary thyroid carcinoma after attribution of multiple endocrine neoplasia type 2 gene carrier status by screening for ret gene mutations. Surgery 118:1031\u20131035","journal-title":"Surgery"},{"key":"0368_CR59","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/S0022-3468(99)90075-1","volume":"34","author":"van","year":"1999","unstructured":"van Heurn LWE, Schaap C, Sie G, Haagen AAM, Gerver WJ, Freling G, van Amstel PHK, Heinemann E (1999) Predictive DNA testing for multiple endocrine neoplasia 2: a therapeutic challenge of prophylactic thyroidectomy in very young children. J Pediatr Surg 34:568\u2013571","journal-title":"J Pediatr Surg"},{"key":"0368_CR60","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1002\/cncr.10228","volume":"94","author":"Sanso","year":"2002","unstructured":"Sanso GE, Domene HM, Garcia Rudaz MC, Pusiol E, de Mondino AK, Ronue M, Ring A, Perinetti H, Elsner B, Iorcansky S, Barotini M (2002) Very early detection of RET proto-oncogene mutation is crucial for preventive thyroidectomy in multiple endocrine neoplasia type 2 children. Cancer 94:323\u2013330","journal-title":"Cancer"},{"key":"0368_CR61","first-page":"42","volume":"6","author":"La-Quaglia","year":"1997","unstructured":"La-Quaglia MP, Telander RL (1997) Differentiated and medullary thyroid cancer in childhood and adolescences. Semin Pediatr Surg 6:42\u201349","journal-title":"Semin Pediatr Surg"},{"key":"0368_CR62","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1093\/jjco\/27.3.128","volume":"27","author":"Iihara","year":"1997","unstructured":"Iihara M, Yamashita T, Okamoto T, Kanabe M, Yamazaki K, Egawa S (1997) A nationwide clinical survey of patients with multiple endocrine neoplasia type 2 and familial medullary carcinoma in Japan. Jpn J Clin Oncol 27:128\u2013134","journal-title":"Jpn J Clin Oncol"},{"key":"0368_CR63","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/S0039-6060(05)80097-2","volume":"118","author":"O'Rioardan","year":"1995","unstructured":"O'Rioardan DS, O'Brien T, Crotty TB, Gharib H, Grant CS, van Heerden JA (1995) Multiple endocrine neoplasia type 2B: more than an endocrine disorder. Surgery 118:936\u2013942","journal-title":"Surgery"},{"key":"0368_CR64","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1007\/s00383-002-0824-1","volume":"18","author":"Torre","year":"2002","unstructured":"Torre M, Martucciello G, Ceccherini I, Lerone M, Aicardi M, Gambini C, Jasonni V (2002) Diagnostic and therapeutic approach to multiple endocrine neoplasia type 2B ind pediatric patients. Pediatr Surg Int 18:378\u2013383","journal-title":"Pediatr Surg Int"},{"key":"0368_CR65","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1067\/msy.2002.128559","volume":"132","author":"Gimm","year":"2002","unstructured":"Gimm O, Niederle BE, Weber T, Bockhorn M, Ukkat J, Brauckhof M, Thanh PN, Frilling A, Klar E, Niederle B, Dralle H (2002) RET proto-oncogene mutations affecting codon 790\/791: a mild form of multiple endocrine neoplasia 2A? Surgery 132:952\u2013959","journal-title":"Surgery"},{"key":"0368_CR66","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1067\/msy.2000.11\/6\/111080","volume":"128","author":"Frohnauer","year":"2000","unstructured":"Frohnauer MK, Decker RA (2000) Update on the MEN 2A c804 RET mutation: is prophylactic thyroidectomy indicated? Surgery 128:1052\u20131058","journal-title":"Surgery"},{"key":"0368_CR67","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1067\/msy.2002.123006","volume":"131","author":"Lecube","year":"2002","unstructured":"Lecube A, Hernandez C, Oriola J, Galard R, Gemar E, Mesa J, Simo R (2002) V804 M RET mutation and familial medullary thyroid carcinoma: report of a large family with expression of the disease only in the homozygous gene carriers. Surgery 131:509\u2013514","journal-title":"Surgery"},{"key":"0368_CR68","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1210\/jcem.87.4.8403","volume":"87","author":"Lombardo","year":"2002","unstructured":"Lombardo F, Baudin E, Chiefari E, Arturi F, Bardett S, Caillou B, Conte C, Dallapiccola B, Guiffrida D, Bidart JM, Schlumberger M, Filetti S (2002) Familial medullary thyroid carcinoma: clinical variability and low aggressiveness associated with RET mutation at codon 804. J Clin Endocrinol Metab 87:1674\u20131680","journal-title":"J Clin Endocrinol Metab"},{"key":"0368_CR69","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1002\/1097-0142(20000815)89:4<863::AID-CNCR19>3.0.CO;2-Z","volume":"89","author":"Hansen","year":"2000","unstructured":"Hansen HS, Terring H, Godballe C, J\u00e4ger AC, Nielsen FC (2000) Is thyroidectomy necessary in RET mutations carriers of the familial medullary thyroid carcinoma syndrome? Cancer 89:863\u2013867","journal-title":"Cancer"},{"key":"0368_CR70","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1007\/s00268-002-6616-x","volume":"26","author":"Dackiw","year":"2002","unstructured":"Dackiw AP, Kuerer HM, Clark OH (2002) Current national health insurance policies for thyroid cancer prophylactic surgery in the United States. World J Surg 26:903\u2013906","journal-title":"World J Surg"}],"container-title":["Langenbeck's Archives of Surgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00423-003-0368-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00423-003-0368-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00423-003-0368-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,11]],"date-time":"2019-12-11T22:13:11Z","timestamp":1576102391000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00423-003-0368-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,3]]},"references-count":70,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2003,3]]}},"alternative-id":["0368"],"URL":"https:\/\/doi.org\/10.1007\/s00423-003-0368-4","relation":{},"ISSN":["1435-2443","1435-2451"],"issn-type":[{"value":"1435-2443","type":"print"},{"value":"1435-2451","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,3]]}}}